- Home
- SAIA vs HALO Comparison
SAIA vs HALO Comparison
Compare SAIA & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAIA
- HALO
- Stock Information
- Founded
- SAIA 1924
- HALO 1998
- Country
- SAIA United States
- HALO United States
- Employees
- SAIA N/A
- HALO N/A
- Industry
- SAIA Trucking Freight/Courier Services
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SAIA Industrials
- HALO Health Care
- Exchange
- SAIA Nasdaq
- HALO Nasdaq
- Market Cap
- SAIA 8.0B
- HALO 7.6B
- IPO Year
- SAIA 2002
- HALO N/A
- Fundamental
- Price
- SAIA $290.37
- HALO $74.46
- Analyst Decision
- SAIA Buy
- HALO Buy
- Analyst Count
- SAIA 18
- HALO 8
- Target Price
- SAIA $374.06
- HALO $70.25
- AVG Volume (30 Days)
- SAIA 533.4K
- HALO 2.2M
- Earning Date
- SAIA 10-24-2025
- HALO 10-30-2025
- Dividend Yield
- SAIA N/A
- HALO N/A
- EPS Growth
- SAIA N/A
- HALO 68.93
- EPS
- SAIA 10.83
- HALO 4.37
- Revenue
- SAIA $3,235,745,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- SAIA $2.27
- HALO $32.57
- Revenue Next Year
- SAIA $6.67
- HALO $23.25
- P/E Ratio
- SAIA $26.85
- HALO $16.76
- Revenue Growth
- SAIA 4.23
- HALO 34.97
- 52 Week Low
- SAIA $229.12
- HALO $42.01
- 52 Week High
- SAIA $624.55
- HALO $74.44
- Technical
- Relative Strength Index (RSI)
- SAIA 46.19
- HALO 85.80
- Support Level
- SAIA $289.41
- HALO $72.07
- Resistance Level
- SAIA $312.62
- HALO $74.07
- Average True Range (ATR)
- SAIA 12.11
- HALO 1.50
- MACD
- SAIA -1.66
- HALO 0.19
- Stochastic Oscillator
- SAIA 12.54
- HALO 89.81
About SAIA Saia Inc.
Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.